Characterization for the similarity assessment between proposed biosimilar SB17 and ustekinumab reference product using state-of-the-art analytical method

被引：0
|
作者：
Yang, S. Y. [1 ]
Lee, C. [1 ]
Hwang, K. [1 ]
Lee, J. [1 ]
Lee, J. [1 ]
Hong, J. [1 ]
Jung, S. [1 ]
机构：
[1] Samsung Bioepis Co Ltd, Qual Evaluat Team, Incheon, South Korea
来源：
JOURNAL OF CROHNS & COLITIS | 2024年 / 18卷
关键词：
D O I：
暂无
中图分类号：
R57 [消化系及腹部疾病];
学科分类号：
摘要：
P134
引用
收藏
页码：I424 / I424
页数：1
相关论文
共 12 条
  • [1] Characterization for the Similarity Assessment Between the Proposed Biosimilar SB17 and Ustekinumab Reference Product Using State-of-the-Art Analytical Methods
    Yang, Sung-Yong
    Lee, Changsoo
    Hwang, Keumbi
    Lee, Jungmin
    Lee, Jaell
    Hong, Juyong
    Jung, Seongyoung
    DRUGS IN R&D, 2025, : 19 - 34
  • [2] Characterization for the Similarity Assessment between Proposed Biosimilar SB12 and Eculizumab Reference Product Using a State-of-the-Art Analytical Method
    Hyunsoo Kim
    Eunkyoung Hong
    Jungmin Lee
    Seokku Hong
    Jihye Kim
    Miju Cho
    Yikwon Kim
    Taekyung Yoo
    BioDrugs, 2023, 37 : 569 - 581
  • [3] Characterization for the Similarity Assessment between Proposed Biosimilar SB12 and Eculizumab Reference Product Using a State-of-the-Art Analytical Method
    Kim, Hyunsoo
    Hong, Eunkyoung
    Lee, Jungmin
    Hong, Seokku
    Kim, Jihye
    Cho, Miju
    Kim, Yikwon
    Yoo, Taekyung
    BIODRUGS, 2023, 37 (04) : 569 - 581
  • [4] Characterization for the Similarity Assessment between SB12 (Eculizumab Biosimilar) and Eculizumab Using State-of-the-Art Analytical Method
    Jang, Jun Ho
    Hong, Eunkyoung
    Kim, Hyunsoo
    Kim, Yikwon
    Yoo, Taekyung
    Lee, Jungmin
    BLOOD, 2022, 140 : 11049 - 11049
  • [5] Analytical Characterization for Similarity Assessment Between an Aflibercept Biosimilar SB15 and Reference Product (Eylea®)
    Lee, Hangyeore
    Huh, Jongcheol
    Kim, Dayoung
    Lee, Soye
    Lee, Jaeil
    Lee, Jungmin
    Kim, Beom Chan
    Song, Jinsu
    OPHTHALMOLOGY AND THERAPY, 2024, 13 (08) : 2209 - 2225
  • [6] A randomized, double-blind, phase III study assessing clinical similarity of SB17 (proposed ustekinumab biosimilar) to reference ustekinumab in subjects with moderate-to-severe plaque psoriasis
    Feldman, Steven R.
    Narbutt, Joanna
    Girolomoni, Giampiero
    Brzezicki, Jan
    Reznichenko, Nataliya
    Zegadlo-Mylik, Maria Agnieszka
    Pulka, Grazyna
    Dmowska-Stecewicz, Magdalena
    Klujszo, Elzbieta
    Rekalov, Dmytro
    Rajzer, Lidia
    Lee, Jiyoon
    Lee, Minkyung
    Rho, Young Hee
    JOURNAL OF THE AMERICAN ACADEMY OF DERMATOLOGY, 2024, 91 (03) : 440 - 447
  • [7] Analytical Similarity Assessment of a Ranibizumab Biosimilar SB11 to Reference Product
    Woo, Se
    Park, Hyerim
    Chae, Yunjung
    Han, Jihyeon
    Kim, Eunji
    Na, Un
    Kim, Beomchan
    INVESTIGATIVE OPHTHALMOLOGY & VISUAL SCIENCE, 2021, 62 (08)
  • [8] A Phase 1, Randomized, Double-Blind, Single-Dose Comparative Pharmacokinetic Study Comparing SB17 (Proposed Ustekinumab Biosimilar) with Reference Ustekinumab in Healthy Subjects
    Jeong, Hansol
    Kang, Taeseung
    Lee, Jiyoon
    Im, Seongsik
    JOURNAL OF THE AMERICAN ACADEMY OF DERMATOLOGY, 2023, 89 (03) : AB9 - AB9
  • [9] Analytical Similarity Assessment of an Aflibercept Biosimilar SB15 to Its Commercially Available Reference Product (Eylea)
    Sagong, Min
    Lee, Hangyeore
    Huh, Jongcheol
    Kim, Dayoung
    Lee, Soye
    Kim, Beomchan
    Song, Jinsu
    Lee, Jungmin
    Bressler, Neil M.
    INVESTIGATIVE OPHTHALMOLOGY & VISUAL SCIENCE, 2023, 64 (08)
  • [10] Biological Characterization of SB3, a Trastuzumab Biosimilar, and the Influence of Changes in Reference Product Characteristics on the Similarity Assessment
    Lee, Jae Hee
    Paek, Kyungyeol
    Moon, Jae Hyon
    Ham, Sunyoung
    Song, Jinsu
    Kim, Seokkyun
    BIODRUGS, 2019, 33 (04) : 411 - 422
12